Medivise

"Medizinische Versorgung. Überall. Jederzeit." — A modular telemedicine platform that brings regulated, TI-connected medical care directly into pharmacies, clinics, care homes, and enterprises, turning any environment into a point of care.

Where it wins

• Regulatory-first deployment: Fully compliant with § 129 Abs. 5h SGB V for assisted telemedicine in pharmacies, with e-prescription and eAU integration [1].
• Modular hardware ecosystem: Offers five distinct deployment formats, from the compact Medivise Air desktop terminal to the full-scale Medivise Care+ box with a stretcher and assistance options [1].
• TI connectivity & security: Built on the German Telematics Infrastructure (TI) with encrypted data processing and medical hygiene standards, ensuring trust and interoperability [1].
• End-to-end workflow: Covers the entire patient journey from digital check-in and AI-supported diagnosis to e-prescription issuance and case closure [1].

Credibility: The platform's compliance with § 129 Abs. 5h SGB V and TI connectivity are explicitly stated on the homepage, alongside the specific hardware dimensions and deployment scenarios [1].

• Hardware-Software Bundle: Selling or leasing physical telemedicine units that serve as the access point for the software platform, creating a tangible product alongside the SaaS [1].
• Regulatory Arbitrage: Capitalizing on the new § 129 Abs. 5h SGB V regulation to enable assisted telemedicine in pharmacies, a newly opened market [1].
• Modular Scalability: Offering a range of hardware sizes and features (from desktop to full care boxes) to fit different budgets and space constraints, scaling revenue per site [1].
• Ecosystem Integration: Acting as the bridge between patients, physicians, and the TI, capturing value from the entire care process rather than just the consultation [1].

• Traditional Telemedicine Providers: Often lack the hardware integration and regulatory compliance for assisted telemedicine [1].
• DIY Solutions: Clinics may attempt to build their own telemedicine setups, lacking TI connectivity and modularity [1].
• Hardware-Only Vendors: Sell telemedicine kiosks but lack the integrated software and regulatory expertise [1].
• Differentiators: Medivise's unique combination of modular hardware, TI connectivity, and regulatory compliance for § 129 Abs. 5h SGB V [1].
• Threats: New entrants with similar regulatory expertise or established healthcare IT players expanding into telemedicine [1].

• Access Barriers: Patients in rural areas or with mobility issues struggle to access timely medical care [1].
• Clinic Overload: Emergency rooms and clinics are overwhelmed with non-critical cases, increasing wait times [1].
• Pharmacy Underutilization: Pharmacies have high foot traffic but limited medical services to offer [1].
• Staff Shortages: Healthcare facilities face staffing shortages, leading to burnout and reduced care quality [1].
• Regulatory Complexity: Navigating the legal and technical requirements for telemedicine is difficult for providers [1].

Medivise is well-positioned to capitalize on the new § 129 Abs. 5h SGB V regulation, which opens up the pharmacy market for assisted telemedicine. Their modular hardware approach allows them to scale quickly across different settings. The main risk is regulatory changes or delays in TI adoption. The opportunity lies in expanding into other European markets with similar regulatory frameworks. The next signal to watch is the adoption rate among pharmacy chains and the success of the July 2026 rollout.

Medivise should focus on building a robust partner ecosystem with diagnostic tool manufacturers to enhance the value of their hardware. They should also invest in data analytics to provide insights to healthcare providers on patient outcomes and operational efficiency. Expanding into international markets with similar regulatory environments could drive growth. Finally, they should develop a self-service onboarding process to reduce implementation costs and speed up deployment.